Vulnerability, beliefs, treatments and economic burden of chronic obstructive pulmonary disease in rural areas in China: A cross-sectional study

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Lou, Peian ^a   Zhu, Yanan ^b   Chen, Peipei ^a   Zhang, Pan ^a   Yu, Jiaxi ^a   Zhang, Ning ^a   Chen, Na ^a   Zhang, Lei ^a   Wu, Hongmin ^b   Zhao, Jing ^b  

^a Center for Disease Control and Prevention of Xuzhou City   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Beliefs; COPD; Economic burden; Treatments; Vulnerability

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST OF ILLNESS; CROSS-SECTIONAL STUDY; ECONOMICS; FEMALE; HEALTH; HUMAN; MALE; MIDDLE AGED; QUESTIONNAIRE; VULNERABLE POPULATION;

ADULT; AGED; AGED, 80 AND OVER; CHINA; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RURAL HEALTH; VULNERABLE POPULATIONS;

EID: 84862212170     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-287     Document Type: Article

References (38)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. 2010. Available from: http://www.goldcopd.org/guidelines-global-strategyfor-diagnosis- management.html. Accessed August 23, 2011.
2. Chronic obstructive pulmonary disease: current burden and future projections. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S, Eur Respir J 2006 27 2 397 412 10.1183/09031936.06.00025805 16452599
3. Projections of global mortality and burden of disease from 2002 to 2030. Mathers CD, Loncar D, PLoS Med 2006 3 11 442 10.1371/journal.pmed.0030442 17132052
4. World Health Organization: World Health Statistics 2008. Geneva: World Health Organization 2008.
5. The burden and impact of COPD in Asia and Africa. Chan-Yeung M, At-Khaled N, White N, Ip MS, Tan WC, Int J Tuberc Lung Dis 2004 8 1 2 14 14974740
6. Prevalence of chronic obstructive pulmonary disease in Chinaa large population based spirometry based cross-sectional survey. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Zhou Y, Liu S, Wang X, Wang D, Lu J, Zheng J, Ran P, Am J Respir Crit Care Med 2007 176 8 753 760 10.1164/rccm.200612-1749OC 17575095
7. Burden and importance of proper management about chronic obstructive pulmonary disease in China. Fang XC, Wang XD, Bai CX, Int J Respir 2011 31 7 493 497
8. Cost analysis of an integrated care model in the management of acute exacerbations of chronic obstructive pulmonary disease. Bakerly ND, Davies C, Dyer M, Dhillon P, Chron Respir Dis 2009 6 4 201 208 19729444
9. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Celli BR, MacNee W, Eur Respir J 2004 23 6 932 946 10.1183/09031936.04.00014304 15219010
10. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. National Collaborating Centre for Chronic Conditions, Thorax 2004 59 Suppl 1 1 232 15041752
11. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Kessler R, Stahl E, Vogelmeier C, Haughney J, Trudeau E, Lofdahl CG, Partridge MR, Chest 2006 130 1 133 142 10.1378/chest.130.1.133 16840393
12. Impact of COPD in North America and Europe in 2000:subjectsperspective of confronting COPD international survey. Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, Vestbo J, Eur Respir J 2002 20 4 799 805 10.1183/09031936.02.03242002 12412667
13. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA, Am J Respir Crit Care Med 2004 169 12 1298 1303 10.1164/rccm.200310-1443OC 14990395
14. Management of COPD in general practice in Denmark - participating in an educational program substantially improves adherence to guidelines. Ulrik CS, Hansen EF, Jensen MS, Rasmussen FV, Dollerup J, Hansen G, Andersen KK, KVASIMODO II study group, Int J Chron Obstruct Pulmon Dis 2010 5 73 79 20463948
15. Attitudes and actions of chronic obstructive pulmonary disease patients on treatment:a national multi-center investigative study. Chen YH, Yao WZ, Kang J, Cai BQ, Zhou X, Liu Z, Chen P, Sun DJ, Zheng JP, Wang GY, Feng YL, Xu YJ, Jia Y, Lu M, Chang C, Wang XH, Chin J Tubec Respir Dis 2010 33 10 750 753
16. Evaluation of clinical significance of chronic obstructive pulmonary disease assessment test. Chai JJ, Liu T, Cai BQ, Chin J Tubec Respir Dis 2011 34 4 256 258
17. Application of vulnerability appraising in constructing theoretical model for early warning of emergent public health event. Fan CF, Yang YF, Cao GW, Acad J Sec Mil Med Univ 2007 28 10 116 119
18. Public Health Emergency Response Mechanism and Assessment System. Chen JC, Wang AM, Wang F, [J] China Inspection and Quarantine 2007 20 02 25 26
19. Diagnosis and treatment guidelines of chronic obstructive pulmonary disease(revised edition in 2007). Chinese Society of Respiratory Disease, chronic obstructive pulmonary disease group, Chin J Intern Med 2007 46 254 261
20. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Am J Respir Grit Care Med 2001 163 5 1256 1276
21. Quality of life measurement for patients with disease of the airways. Jones PW, Thorax 1991 46 9 676 682 10.1136/thx.46.9.676 1835178
22. Attitudes and actions of asthma patients on regular maintenance therapy:the INSPIRE study. Partridge MR, van der Molen T, Myrseth SE, Busse WW, BMC Pulm Med 2006 6 13 10.1186/1471-2466-6-13 16772035
23. Living quality evaluation of the patients of Chronic obstructive pulmonary disease. Cai YY, Li ZZ, Fang ZJ, Chin J Gen Pract 2004 3 4 225 227
24. Year of potential life lost before ages 65 and 85,United States,1989-1990. CDC, MMWR 1992 18 313
25. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, Carter R, Sharafkhaneh A, Goepfert EJ, Wray N, Stanley MA, Psychol Med 2008 38 3 385 396 17922939
26. Awareness of risk factors among persons at risk for lung cancer, chronic obstructive pulmonary disease and sleep apnea: A Canadian population-based study. Walker SL, Saltman DL, Colucci R, Martin L, Can Respir J 2010 17 6 287 294 21165351
27. Patient's perspective of chronic obstructive pulmonary disease in Yanqing County of Beijing. Ning S, Wanzhen Y, Hong Z, Chin J Tuberc Respir Dis 2008 31 3 206 208
28. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, Van-Wel C, Zielinski J, Am J Respir Crit Care Med 2007 176 6 532 555 10.1164/rccm.200703-456SO 17507545
29. Community based integrated intervention for prevention and management of chronic obstructive pulmonary disease(COPD)in Guangdong. China:cluster randomised controlled trial. Zhou Y, Hu G, Wang D, Wang S, Wang Y, Liu Z, Hu J, Shi Z, Peng G, Liu S, Lu J, Zheng J, Wang J, Zhong N, Ran P, BJM 2010 341 6387 10.1136/bmj.c6387
30. Long-acting anticholinergic use in chronic obstructive pulmonary disease:efficacy and safety. Tashkin DP, Curr Opin Pulm Med 2010 16 2 97 105 10.1097/MCP.0b013e328335df1e 20019615
31. Prevention of exacerbations of COPD with pharmacotherapy. Miravitlles M, Eur Respir Rev 2010 19 116 19 l126
32. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Barr RG, Celli BR, Mannino DM, Petty T, Rennard SI, Sciurba FC, Stoller JK, Thomashow BM, Turino GM, Am J Med 2009 122 4 348 355 10.1016/j.amjmed.2008.09.042 19332230
33. Medication adherence issues in patients treated for COPD. Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, Sikkema-Ortiz J, Gardner DD, Wilkins RL, Int J Chron Obstruct Pulmon Dis 2008 3 3 371 384 18990964
34. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O'Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T, Am J Respir Crit Care Med 2006 173 12 1390 1413 10.1164/rccm.200508-1211ST 16760357
35. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S, Chest 2004 125 6 2011 2020 10.1378/chest.125.6.2011 15189916
36. Years of potential life lost of chronic obstructive pulmonary diseases among residents in Nanjing from 1997 to 2005. Xu F, Liang YQ, Shen HB, Xu YC, Chin J Epidemiol 2007 28 2 203 204
37. Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. Carrasco-Garrido P, de Miguel-Díez J, Rejas-Gutierrez J, Martín-Centeno A, Gobartt-Vázquez E, Hernandez-Barrera V, de Miguel AG, Jimenez-Garcia R, BMC Pulm Med 2009 9 2 10.1186/1471-2466-9-2 19121205
38. Direct costs of chronic obstructive pulmonary disease among managed care patients. Dalal AA, Christensen L, Liu F, Riedel AA, Int J Chron Obstruct Pulmon Dis 2010 5 341 349 21037958